MedPath
HSA Approval

FUCIDIN H CREAM

SIN10834P

FUCIDIN H CREAM

FUCIDIN H CREAM

March 24, 1999

DKSH SINGAPORE PTE. LTD.

DKSH SINGAPORE PTE. LTD.

Regulatory Information

DKSH SINGAPORE PTE. LTD.

DKSH SINGAPORE PTE. LTD.

Therapeutic

Prescription Only

Formulation Information

CREAM

**Dosage** Apply the cream three times daily for up to 2 weeks.

TOPICAL

Medical Information

**Indications** Fucidin® H Cream is indicated for the treatment of dermatitis, including atopic dermatitis and contact dermatitis, where an infection with bacteria sensitive to fusidic acid is suspected or confirmed. Because of its hydrocortisone content, Fucidin® H Cream is particularly appropriate in cases where a milder corticosteroid is indicated, including milder inflammatory dermatoses – on the face and on children’s skin. Fucidin® H Cream is cosmetically acceptable for use on the face and hands and convenient for use in the armpits.

**Contraindications** Hypersensitivity to fusidic acid/sodium fusidate, hydrocortisone acetate or to any of the excipients listed above (see Composition – _please refer to the Product Insert/Patient Information Leaflet published on HSA for the full drug information_). Due to the content of corticosteroid, Fucidin® H is contraindicated in the following conditions: Primary skin infections caused by fungi, virus or bacteria, either untreated or uncontrolled by appropriate treatment (see Special warnings and precautions for use – _please refer to the Product Insert/Patient Information Leaflet published on HSA for the full drug information_). Skin manifestations in relation to tuberculosis, either untreated or uncontrolled by appropriate therapy. Perioral dermatitis and rosacea.

D07CA01

hydrocortisone and antibiotics

Manufacturer Information

DKSH SINGAPORE PTE. LTD.

LEO Laboratories Limited

Active Ingredients

FUSIDIC ACID

20 mg/g

Fusidic acid

HYDROCORTISONE ACETATE

10 mg/g

Documents

Package Inserts

Fucidin H Cream PI.pdf

Approved: October 9, 2019

Download
© Copyright 2025. All Rights Reserved by MedPath